The youngest member of the bioinformatics community is Sarah Morgan Sasinowska, daughter of Incogen heads Maciek Sasinowski and Heather Sasinowska. Born October 24 at 8 lbs., 8 oz., Sarah already has been welcomed to the Incogen family with a series of photos on the website.
The rumors have finally been confirmed: Gene Myers will leave his post as VP of informatics research at Celera Genomics in January to become a professor at the University of California, Berkeley, in the department of electrical engineering and computer sciences, where he will continue to work in computational biology.
Marshall Peterson, who helped build the Celera supercomputer and left the company before Craig Venter did, is in charge of IT for Venter’s new centers.
It’s the SNPs chairman name game: Orchid BioSciences selected George Poste to be chairman of the board, replacing Dale Pfost (also pronounced “post”), who remains president and CEO of the company. Orchid also chose Andrew Savadelis as CFO.
Richard Resnick, who has in the past worked for Mosaic Bioinformatics and NetGenics, climbed aboard at Gene-IT as vice president of service operations.
Functional genomics firm GenOdyssee appointed Jean-Marc Giry VP of strategic planning; Philippe Remes VP of investor relations; and David Briscoe VP of business development.
High Throughput Genomics hired Kirk Collamer as VP and CFO. Collamer came to the Tucson, Ariz.-based company from Pointshare, a technology provider.
Christine Arakelian emerged from independent consulting to join Large Scale Biology as senior director of business development.
Joseph Limber, president and CEO of Aclara Biosciences, will resign both positions at the start of this month.
Genome Express, a French functional genomics company based in Grenoble, hired Francois Pons from Centre d’Immunologie Pierre Fabre as director of business development.
Jason Rubin joined Incyte Genomics in the new position of executive vice president of corporate affairs. Rubin has worked for Cephalon, Centocor, and Immunex, as well as for his own communications consulting firm.
Lyn Leaper, most recently at Stratagem Intellectual Property Management, headed to Astex Technology as vice president of IP.
EuropaBio (think BIO for Europe) chose Feike Sijbesma as chairman of the board.
Cepheid announced that it was eliminating 25 staff members and 14 contractor positions as part of a realignment of strategic goals.
Protedyne, an automation and tool company based in Windsor, Conn., appointed Donald Schoeny as president and CEO. Schoeny came to Protedyne from CytoLogix, an instrument and reagent supplier, and replaced co-founder Stan Klein, who will remain as veep of business development.
Huntington Willard was hired as director for the two-year old Duke University Institute for Genome Sciences and Policy. Willard was previously an institute director in Cleveland.
Dharmacon announced that Rosalie Duong filled its COO position. Formerly VP and general manager for Qiagen, she will head up sales and marketing, finance, and IT.
It''s promotion season at Caliper Technologies. Anne Kopf-Sill, former senior director of genetic analysis, became senior veep of new products and will manage design and development of LabChip products. Robert Nagle, a research fellow and director of engineering at Caliper, was named VP of product development. And Anthony Hendrickson, Caliper''s comptroller and chief accounting officer, was named vice president of finance.